health pharma news today obesity drugs glp-1 Most do not improve quality of life or heart health, analysis indicates Recent medical advancements in weight

2018;11(suppl 1):1358

Optimizing dosing schedules and administration routes is critical to maximize therapeutic efficacy while minimizing adverse effects such as hypoglycemia and gastrointestinal intolerance

As compounding pharmacies continue to develop around additive combinations, pharmaceutical stakeholders must closely monitor the clinical and regulatory implications

You are unable to take oral fluids

1,2 Following a meal, GLP-1 facilitates glucose-dependent insulin secretion from pancreatic -cells, suppresses glucagon release from -cells, and slows gastric emptying, all of which moderate glucose excursions following nutrient intake